Industrial Policy & Trade Monitor· 2662 actions· ✨ 89 recent

On June 2, 2026, USTR published final actionability findings in 60 parallel Section 301(b) investigations — the largest simultaneous Section 301 action in US history — determining that all 60 economies maintain unreasonable acts, policies, or practices by failing to impose or effectively enforce a prohibition on imports produced with forced labor. USTR proposed two additional duty rates: 10% on the 14 economies with partial forced-labor regimes (Canada, Ecuador, EU, Indonesia, Mexico, Pakistan, Argentina, Bangladesh, Cambodia, El Salvador, Guatemala, Malaysia, Taiwan, UK) and 12.5% on the remaining 46 economies. Tariff rates remain proposed pending a July 7, 2026 public hearing and subsequent finalization; the actionability determination is final.

On 2 April 2026 President Trump issued a Presidential Proclamation under Section 232 of the Trade Expansion Act of 1962 ("Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States") imposing a 100% ad valorem tariff on imports of patented pharmaceutical products listed in the FDA Orange Book and Purple Book, together with the active pharmaceutical ingredients (APIs) and key starting materials used to make them. The base rate takes effect at 12:01 a.m. EDT on 31 July 2026 for the 17 manufacturers identified in Annex III, and on 29 September 2026 for all other companies. The proclamation adopts findings of the Section 232 investigation initiated by the Department of Commerce on 14 April 2025 into pharmaceuticals and APIs as a national- security supply-chain risk. The instrument is structured around a multi-tier rate ladder rather than a flat tariff: concessionary 15% rates for EU/Japan/South Korea/Switzerland/Liechtenstein under reciprocal-deal tracks, 10% for the UK with a pathway to 0% under the pending UK pharmaceutical agreement, a "+20%" surcharge for companies operating under a Commerce-approved onshoring plan (until 2 April 2030), and a 0% pathway for companies that combine an approved onshoring plan with an MFN-pricing agreement with HHS (until 20 January 2029). Generics, biosimilars and their ingredients, orphan drugs, nuclear medicines, plasma-derived therapies, fertility treatments, and cell/gene therapies are carved out.

On 11 March 2026 USTR Ambassador Jamieson Greer initiated parallel Section 301 investigations into the acts, policies, and practices of 16 economies — China, the European Union, Singapore, Switzerland, Norway, Indonesia, Malaysia, Cambodia, Thailand, Korea, Vietnam, Taiwan, Bangladesh, Mexico, Japan, and India — relating to structural excess capacity and overproduction in manufacturing sectors. The Federal Register notice (FR doc 2026-05214; dockets USTR-2026-0067 and USTR-2026-0068) was published on 17 March 2026. Covered sectors include aluminum, automobiles, batteries, cement, chemicals, electronics, energy goods, glass, machine tools, machinery, paper, plastics, processed food and beverages, robotics, satellites, semiconductors, ships, solar modules, steel, and transportation equipment. Written comments were due by 15 April 2026; USTR held the public hearing beginning 5 May 2026. This is the most sweeping multi-economy Section 301 initiative since the 2018 China investigation and is structurally distinct from the China-only 2024-05-14 §301 tariff hikes and the 2025-07-15 Brazil §301 investigation.

President Trump signed a Presidential Proclamation on 20 February 2026 invoking Section 122 of the Trade Act of 1974 (19 U.S.C. § 2132) to impose a temporary 10% ad-valorem import surcharge on articles imported into the United States, effective 12:01 a.m. EST on 24 February 2026. The proclamation was issued within hours of the US Supreme Court's 20 February 2026 ruling in Learning Resources, Inc. v. Trump, which held that the International Emergency Economic Powers Act (IEEPA) does not authorize the president to set tariffs and vacated the IEEPA-based reciprocal-tariff regime previously in effect. The Section 122 surcharge is statutorily limited to 150 days (terminates 24 July 2026 absent Congressional extension) and the statute caps any such surcharge at 15% ad valorem. Goods qualifying as USMCA originating from Canada or Mexico are exempt; CAFTA-DR textile/apparel articles meeting specified rules of origin are exempt; and a substantial product-exception list excludes critical minerals, energy products, certain pharmaceuticals, electronics, vehicles, aerospace products, specified agricultural goods, and goods already subject to Section 232 duties (the Section 122 duty does not stack on Section 232).

On 11 December 2025 the US Department of State announced the inaugural Pax Silica Summit, held in Washington D.C. on 12 December 2025, at which the United States, Australia, Japan, the Republic of Korea, the United Kingdom, Singapore and Israel signed the non-binding Pax Silica Declaration. The declaration commits signatories to coordinate "trusted" supply chains across the full technology stack — software, frontier foundation models, network infrastructure, compute and semiconductors, advanced manufacturing, transportation logistics, minerals refining and processing, and energy — explicitly to reduce "coercive dependencies." The coalition has since expanded to add the United Arab Emirates, Greece, Qatar, Sweden and India (signed 20 February 2026 at the India AI Impact Summit), and on 26 March 2026 State announced a USD 250 million Pax Silica Fund intended to catalyse trusted-capital co-investment in critical-minerals processing and semiconductor supply chains.

President Trump signed Proclamation 10984 "Adjusting Imports of Medium- and Heavy-Duty Vehicles, Medium- and Heavy-Duty Vehicle Parts, and Buses Into the United States" on 17 October 2025, invoking Section 232 of the Trade Expansion Act of 1962 to impose a 25% ad valorem tariff on imports of Class 3 to Class 8 medium- and heavy-duty trucks (large pick-up trucks, moving trucks, cargo trucks, dump trucks, tractors) and on key MHDV parts, and a 10% ad valorem tariff on buses and other vehicles classified in HTSUS heading 8702. Duties take effect at 12:01 a.m. EDT on 1 November 2025 (Federal Register doc 2025-19639, 90 FR 48451, published 22 October 2025). USMCA-qualifying MHDVs are tariffed only on the value of non-U.S. content; the proclamation also establishes an offset programme for MHDV parts equal to 3.75% of the aggregate value of all MHDVs assembled in the United States from 2025 through 2030, mirroring the Proclamation 10925 light-vehicle offset architecture.

President Trump signed Executive Order 14345 on 4 September 2025, implementing the July 2025 US-Japan trade agreement by setting a 15% baseline ad-valorem tariff on nearly all Japanese goods — raising any Column 1 (MFN) duty rate below 15% up to that floor, including on agricultural lines such as cereals, vegetables, and fruits and nuts. The modification applies retroactively to Japanese products entered for consumption on or after 12:01 a.m. EDT, 7 August 2025, and supersedes the higher 24% country-specific reciprocal rate Japan faced under the April 2025 "Liberation Day" schedule. Aerospace products are exempted entirely, autos/auto parts receive the same 15% treatment (down from a separate 25% Section 232 rate), and Japan committed to $550bn in US investment and $8bn/year in additional US agricultural purchases (rice, corn, soybeans, fertilizer, bioethanol) as consideration.

President Trump signed Executive Order 14257 on 2 April 2025 declaring a national emergency over US trade deficits and imposing a baseline 10% ad-valorem tariff on imports from nearly all trading partners effective 5 April, with higher country-specific "reciprocal" rates effective 9 April. The rate schedule was constructed from a formula tied to bilateral goods-trade deficits and ranged from 10% (UK, Singapore, Brazil, Australia, others) through 20% (EU), 24% (Japan), 25% (Korea), 32% (Taiwan, Indonesia, Switzerland), 34% (China, later raised to 84% then 125% during the April escalation), 46% (Vietnam), 49% (Cambodia). Multiple subsequent EOs paused the country-specific rates for 90 days for non-China destinations on 9 April while keeping the 10% baseline, pending bilateral negotiations.

President Trump signed Proclamation 10908 "Adjusting Imports of Automobiles and Automobile Parts Into the United States" on 26 March 2025, invoking Section 232 of the Trade Expansion Act of 1962 to impose a 25% ad valorem tariff on imports of finished passenger vehicles and light trucks effective 12:01 a.m. EDT on 3 April 2025, with the duty extended to key automobile parts (engines and engine parts, transmissions and powertrain components, electrical components) effective 12:01 a.m. EDT on 3 May 2025. USMCA-origin automobiles receive an interim deduction equal to the value of US-origin content; USMCA-origin parts that satisfy the agreement's rules of origin are temporarily exempt from the parts duty pending a Commerce-administered process. The proclamation is the first Section 232 instrument applied to finished automobiles in US history and the largest-by-trade-volume Section 232 measure of the second Trump administration, covering roughly USD 460 billion of annual auto and auto-parts imports.

President Trump signed two Presidential Proclamations on 11 February 2025 reinstating a universal 25% ad-valorem tariff on all steel-mill products and raising the aluminum tariff from 10% to 25% on all imports into the United States, effective 12 March 2025. The proclamations revoked every bilateral exclusion and quota arrangement negotiated by the Biden administration with the EU, UK, Japan, Korea, Australia, and others under the 2021-2022 "alternative measures" frameworks, returning all trading partners to the baseline Section 232 rate without product-level or country-level carve-outs.

The Bureau of Industry and Security (BIS) issued a final rule on 16 October 2024 revising paragraph (c) of 15 CFR § 740.24 (License Exception Implemented Export Controls, "IEC") to update the version date of the IEC Eligible Items and Destinations table incorporated by reference and to replace the long URL pointing to that table with the simpler address www.bis.gov/IEC. The underlying table update — posted to the BIS website on 17 September 2024 — adds Denmark and Finland as IEC-eligible destinations and modifies the entries for Japan. License Exception IEC is the mechanism by which BIS authorises shipments of the September 2024 plurilateral export-control items (advanced semiconductor, quantum, and additive-manufacturing technologies) to destinations whose governments have implemented substantially equivalent controls.

Bureau of Industry and Security final rule (89 FR 14403, Doc 2024-03674) adding two entities under seven entries to the Entity List, effective February 27, 2024. Sandvine Incorporated, a Canadian deep packet inspection vendor, is listed across six destinations (Canada, India, Japan, Malaysia, Sweden, UAE) because it supplies DPI technology to the Government of Egypt where it is used for mass web-monitoring and censorship. Chengdu Beizhan Electronics Co., Ltd. is listed under China for acquiring and attempting to acquire U.S.-origin items on behalf of the University of Electronic Science and Technology of China (UESTC), a PLA-affiliated institution already on the Entity List. All items subject to the EAR require a license with a presumption-of-denial review policy for both entities. The rule also revises entries for two existing Chinese entities and removes one UAE entry.

On 8 December 2023 the Bureau of Industry and Security (BIS) published a direct final rule (88 FR 85479; FR Doc 2023-26532) making two export-liberalisation amendments to the Export Administration Regulations (EAR). First, BIS removes Chemical and Biological Weapons (CB) proliferation column controls from the Commerce Country Chart for exports of certain pathogens and toxins (ECCNs 1C351, 1C353, and 1C354) when destined to Australia Group (AG) member countries, on the basis that AG members operate equivalent domestic CBW-export controls. Second, the rule revises the Crime Control and Detection (CC) column entries for Austria, Finland, Ireland, Liechtenstein, South Korea, Sweden, and Switzerland, reflecting the updated US assessment of those countries' law-enforcement export-control standards. Both changes are effective on publication and reduce US export-licensing burdens for allied-country destinations without altering controls for non-allied markets.

The Bureau of Industry and Security added 36 entities — 35 in China, 1 in Japan — to the Entity List under a presumption of denial for all EAR-controlled items, effective December 16, 2022. The most consequential additions are Yangtze Memory Technologies (YMTC, simultaneously removed from the Unverified List), eight Cambricon AI-chip subsidiaries, and Shanghai Micro Electronics Equipment (SMEE), China's sole domestic lithography producer. Three existing entries were revised: CETC 13 and two affiliates gained a Footnote 3 Russian-military-end-user designation, bringing them under the Russia/Belarus Foreign Direct Product rule with a blanket denial policy.

The US Bureau of Industry and Security (BIS) amended the Export Administration Regulations (EAR) effective November 26, 2021, by adding 28 entries to the Entity List across China (12), Japan (1), Pakistan (13 including 2 individuals), Singapore (1), and Taiwan (1). Designations span three distinct threat clusters: (1) eight Chinese entities supporting military applications of quantum computing, including QuantumCTek Co. and the Hefei National Laboratory for Physical Sciences at Microscale; (2) approximately twelve Pakistani procurement entities and three Chinese suppliers facilitating Pakistan's unsafeguarded nuclear activities and ballistic missile program; and (3) the Corad Technology network across China, Japan, Singapore, and Taiwan that sold Western technology to Iran's military/space programs and North Korean front companies. Additionally, the Moscow Institute of Physics and Technology was added to the Military End-User (MEU) List for producing military products. All Entity List entries carry presumption-of-denial licensing policy with no exceptions available.